Evidence map›Paper›PMID 30449272›Full record

ArticleParasites & vectors2018

Efficacy of fluralaner plus moxidectin (Bravecto® Plus spot-on solution for cats) against Otodectes cynotis infestations in cats.

Janina Taenzler, Christa de Vos, Rainer K A Roepke, Anja R Heckeroth

Open access · goldAbstract read
In one paragraph

Article in Parasites & vectors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. The most effective systemic treatment in cats with otodectic mange: A critically appraised topic.The Canadian veterinary journal = La revue veterinaire canadienne · 2025
    Review
  8. Efficacy of BravectoParasites & vectors · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Protecting dogs and cats against the Australian paralysis tick,Current research in parasitology & vector-borne diseases · 2021
    Review
  15. Article
  16. Open veterinary journal
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Janina TaenzlerMSD Animal Health Innovation GmbH, Research Antiparasitics, Zur Propstei, 55270, Schwabenheim, Germany. janina.taenzler@msd.de.
Christa de VosClinvet, Uitsig Road, Bainsvlei, Bloemfontein, 9338, South Africa.
Rainer K A RoepkeMSD Animal Health Innovation GmbH, Research Antiparasitics, Zur Propstei, 55270, Schwabenheim, Germany.
Anja R HeckerothMSD Animal Health Innovation GmbH, Research Antiparasitics, Zur Propstei, 55270, Schwabenheim, Germany.
Clinvet · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe efficacy of the fixed combination of fluralaner plus moxidectin for the treatment of Otodectes cynotis infestations was evaluated in cats after topical application.

methodsSixteen cats experimentally infested with O. cynotis were allocated randomly to two groups of 8 cats each. One group was treated topically with the fixed combination of fluralaner plus moxidectin at the minimum dose rate of 40 mg fluralaner and 2 mg moxidectin/kg body weight. The other group was treated with physiological saline solution. Before and 14 and 28 days after treatment the ears of all cats were examined otoscopically for live mites and for the amount of debris and cerumen. Twenty-eight days after treatment, the cats were sedated and had both ears flushed to obtain the total number of live mites per animal. Efficacy was calculated, based on the results of the ear flushing, by comparing mean live mite counts in the fluralaner plus moxidectin treated group versus the saline group.

resultsA single topical application of the fixed combination of fluralaner plus moxidectin to cats reduced the mean mite counts by 100% (P < 0.001) by 28 days after treatment. No mites were visible during otoscopic examination at either 14 or 28 days after treatment. All fluralaner plus moxidectin treated cats had less ceruminous exudate 28 days after treatment compared to pre-treatment and 14 days after treatment. No treatment related adverse events were observed in any cats enrolled in the study.

conclusionsSingle topical application of the fixed combination of fluralaner plus moxidectin was highly effective against O. cynotis infestations in cats.

Indexed as

Administration, TopicalAnimalsCat DiseasesCatsDrug Therapy, CombinationFemaleInsecticidesIsoxazolesMacrolidesMaleMite InfestationsOtitis ExternaOtoscopyPharmaceutical SolutionsPsoroptidaeRandom AllocationA1443 compoundInsecticidesIsoxazolesMacrolidesmoxidectinPharmaceutical SolutionsBravecto PlusCatCeruminous exudateEar miteFluralanerIsoxazolineMiticideOtitis externaOtocariosisOtodectes cynotisSpot-onTopical

Identifiers

PMID30449272
PMCPMC6241040
OpenAlexW2901028692

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.